Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. SanBio Company Limited
  6. News
  7. Summary
    4592   JP3336750009

SANBIO COMPANY LIMITED

(4592)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SanBio Company Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2022

09/14/2021 | 05:30am EDT

SanBio Company Limited provided consolidated earnings guidance for the fiscal year ending January 31, 2022. For the period, the company expects operating loss of JPY 5,786 million, ordinary loss of JPY 5,876 million and net loss attributable to owners of parent of JPY 5,877 million or JPY 113.49 per share.


ę S&P Capital IQ 2021
All news about SANBIO COMPANY LIMITED
10/18SANBIO : Notice on Appointment of New Corporate Officer
PU
10/18Sanbio Company Limited Appoints Naoki Tsukahara as New Corporate Officer and Business H..
CI
10/14SANBIO : Announcement on Granting Stock Options (Share Acquisition Rights)
PU
09/22SanBio Records Non-Operating Income, Extraordinary Loss in H1
MT
09/21SANBIO : Notice on Recording of Non-Operating Income and Extraordinary Loss
PU
09/16SANBIO : Presentation for Financial Results for the 2nd Quarter of the Fiscal Year Ending ..
PU
09/14SANBIO : Consolidated Financial Results for the Six Months Ended July 31, 2021
PU
09/14SanBio Company Limited Announces Consolidated Earnings Results for the Six Months Ended..
CI
09/14SanBio Company Limited Provides Consolidated Earnings Guidance for the Fiscal Year Endi..
CI
09/14SANBIO : Notice Concerning Difference Between Consolidated Financial Forecasts and Actual ..
PU
More news
Financials
Sales 2022 - - -
Net income 2022 -5 497 M -48,3 M -48,3 M
Net cash 2022 17 541 M 154 M 154 M
P/E ratio 2022 -11,7x
Yield 2022 -
Capitalization 65 311 M 572 M 574 M
EV / Sales 2022 -
EV / Sales 2023 32,1x
Nbr of Employees 85
Free-Float 56,1%
Chart SANBIO COMPANY LIMITED
Duration : Period :
SanBio Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANBIO COMPANY LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Last Close Price 1 224,00 JPY
Average target price 2 660,00 JPY
Spread / Average Target 117%
EPS Revisions
Managers and Directors
Keita Mori President, CEO & Representative Director
Toru Kawanishi Chairman
Bijan Nejadnik Chief Medical Officer & Executive Officer
Chris sanbio Horan Chief Technical Operations Officer
Akihiro Tsujimura COO, Representative Director & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
SANBIO COMPANY LIMITED-8.45%555
GILEAD SCIENCES, INC.16.25%84 921
BIONTECH SE258.67%70 618
WUXI APPTEC CO., LTD.23.63%64 231
REGENERON PHARMACEUTICALS22.57%61 565
VERTEX PHARMACEUTICALS-22.12%47 753